Veracyte, Inc. revenue breakdown overview

Veracyte, Inc. revenue for the last year amounted to 361.05 M USD, the most of which — 361.05 M USD — came from its highest performing source at the moment, Diagnostic Products and Biopharmaceutical Services, the year earlier bringing 296.54 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Veracyte, Inc. 334.52 M USD, and the year before that — 262.92 M USD.